Inquis Medical Announces $40 Million Series B Financing to Accelerate Advancement of Aventus Thrombectomy System Addressing Venus Thromboembolic Diseases

[#item_full_content]MENLO PARK, Calif.–(BUSINESS WIRE)– #cardiology–Inquis Medical closed a $40 million Series B financing to accelerate advancement of its Aventus Thrombectomy System.

Leave a Reply

Your email address will not be published. Required fields are marked *